RESEARCH

What if your healthcare growth strategy is generating activity: but not enough qualified pipeline, sales velocity, or revenue? In specialized healthcare markets, growth does not come from adding more disconnected campaigns. It comes from building an architecture: a connected system that converts market intelligence into buyer-group insight, intent data into timely action, and demand generation […]

Are you tired of chasing "ghost" leads? You know the ones: the accounts that show "high intent" because someone downloaded a whitepaper or browsed your pricing page for three minutes, only to go silent the moment your SDR picks up the phone. In the high-stakes world of B2B growth, Intent Data has long been the

Is your sales pipeline suffering from a "visibility gap"? You are likely investing heavily in traditional marketing, yet watching your competitors secure high-value contracts before you even know the prospect is in-market. In 2026, the traditional lead-gen model is dead. Most B2B buyers now conduct 70% to 90% of their research in the "Dark Funnel",

Healthcare growth is no longer driven by broad segmentation, generic surveys, or a single database export. Your buyers are more specialized, your buying committees are larger, and your commercial decisions carry greater operational, regulatory, and financial risk. A medtech company must satisfy clinicians, procurement, finance, and biomedical engineering. A pharma organization must understand commercial leaders,

Is your demand generation engine firing on all cylinders, or does it feel like you’re swimming through molasses? You’re investing heavily in content, running complex paid social campaigns, and your CRM is bursting with "leads": yet the needle on revenue isn't moving fast enough. Why? The answer is Organizational Drag. In high-growth B2B environments, organizational

Healthcare B2B growth is no longer won by collecting more leads or publishing another quarterly market report. It is won by identifying the accounts with a real business need, understanding the buying committee behind that need, and activating the right message before a competitor earns preferred-vendor status. That is the intent-to-revenue flywheel. Healthcare market research

In the previous installments of the Market Research & Growth Strategies – Alternate Day Phase series, you established the alternate-day playbook, built a living research engine, and connected evidence to your go-to-market strategy. Now, the operating model must evolve again. Healthcare B2B growth in 2026 will not be won by static reports, disconnected spreadsheets, or

Are you tired of chasing "ghost" leads that never convert? In the hyper-competitive B2B landscape, waiting for a prospect to land on your website is no longer a viable growth strategy. By the time they fill out your "Contact Us" form, they have likely completed 70% of their buyer journey: and your competitors might already

Is your AI strategy driving revenue or driving your customers away? In the 2026 marketing landscape, the difference between a high-performing growth engine and a brand-damaging liability is a single word: Governance. The "AI Gold Rush" has transformed from a frantic sprint for tools into a disciplined marathon for trust. Businesses that treat Artificial Intelligence